Sulfo-NHS-LC-Biotin, biotinylating reagent (ab145611)
Key features and details
- Primary amine reactive intermediate-length biotinylating reagent
- CAS Number: 191671-46-2
- Purity: > 90%
- Soluble in water to 25 mM
- Form / State: Solid
- Source: Synthetic
Overview
-
Product name
Sulfo-NHS-LC-Biotin, biotinylating reagent -
Description
Primary amine reactive intermediate-length biotinylating reagent -
Purity
> 90% -
General notes
This product is manufactured by BioVision, an Abcam company and was previously called 2326 Sulfo-NHS-LC-Biotin. 2326-100 is the same size as the 100 mg size of ab145611.
-
CAS Number
191671-46-2 -
Chemical structure
Properties
-
Chemical name
2,5-Dioxo-1-[6-[5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanoylamino]hexanoyloxy]pyrrolidine-3-sulfonic acid sodium salt -
Molecular weight
556.59 -
Molecular formula
C14H18O8N3S2Na -
PubChem identifier
71571498 -
Storage instructions
Store at -20°C. Store under desiccating conditions. The product can be stored for up to 12 months. -
Solubility overview
Soluble in water to 25 mM -
Handling
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Refer to SDS for further information.
Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
-
SMILES
O=C2NC3C(CCCCC(=O)NCCCCCC(=O)ON1C(=O)CC(C1=O)S(=O)(=O)O[Na])SCC3N2 -
Source
Synthetic
-
Research areas
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
Datasheets and documents
-
SDS download
-
Datasheet download
References (4)
ab145611 has been referenced in 4 publications.
- Ma N et al. Tankyrase inhibition interferes with junction remodeling, induces leakiness, and disturbs YAP1/TAZ signaling in the endothelium. Naunyn Schmiedebergs Arch Pharmacol 397:1763-1789 (2024). PubMed: 37741944
- Chao YY et al. Human TH17 cells engage gasdermin E pores to release IL-1α on NLRP3 inflammasome activation. Nat Immunol 24:295-308 (2023). PubMed: 36604548
- Lee KP et al. Functional identification of protein phosphatase 1-binding consensus residues in NBCe1-B. Korean J Physiol Pharmacol 22:91-99 (2018). PubMed: 29302216
- Suzuki Y et al. TRPV6 Variants Interfere with Maternal-Fetal Calcium Transport through the Placenta and Cause Transient Neonatal Hyperparathyroidism. Am J Hum Genet 102:1104-1114 (2018). PubMed: 29861107